Home
VRNA
VRNA News

Latest Verona Pharma plc (VRNA) News on September 18, 2025

Verona Pharma (VRNA) Rebounded from Challenging Q1

Insider Monkey

2 days ago

Verona Pharma (VRNA) Rebounded from Challenging Q1

Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025

GlobeNewswire

2 days ago

Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025

Does Verona Pharma's Recent FDA Approval Rally Signal Further Upside in 2025?

Simply Wall St.

5 days ago

Does Verona Pharma's Recent FDA Approval Rally Signal Further Upside in 2025?

Here’s What Boosted Verona Pharma plc (VRNA) Share Price by 49%

Insider Monkey

6 days ago

Here’s What Boosted Verona Pharma plc (VRNA) Share Price by 49%

Verona Pharma price target raised to $160 from $76 at Piper Sandler

TipRanks

3 months ago

Verona Pharma price target raised to $160 from $76 at Piper Sandler

Up 515%, Watch This Biopharma Breakout

Barchart

3 months ago

Up 515%, Watch This Biopharma Breakout

Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch

Insider Monkey

3 months ago

Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch

Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today

Motley Fool

3 months ago

Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today

Jim Cramer Notes Verona Pharma plc (VRNA) “Loses a Lot of Money”

Insider Monkey

4 months ago

Jim Cramer Notes Verona Pharma plc (VRNA) “Loses a Lot of Money”

Verona Pharma Announces June 2025 Investor Conference Participation

GlobeNewswire

4 months ago

Verona Pharma Announces June 2025 Investor Conference Participation

Why Verona Pharma plc (VRNA) is Among the Best Performing Healthcare Stocks to Buy Now

Insider Monkey

4 months ago

Why Verona Pharma plc (VRNA) is Among the Best Performing Healthcare Stocks to Buy Now

What Makes Verona Pharma plc (VRNA) a Good Investment?

Insider Monkey

4 months ago

What Makes Verona Pharma plc (VRNA) a Good Investment?

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout

Investor's Business Daily

4 months ago

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025

GlobeNewswire

4 months ago

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025

MT Newswires

5 months ago

Verona Pharma Insider Sold Shares Worth $811,433, According to a Recent SEC Filing

Why Verona Pharma plc (VRNA) Soared on Tuesday

Insider Monkey

5 months ago

Why Verona Pharma plc (VRNA) Soared on Tuesday

Analysts Are Betting On Verona Pharma plc (NASDAQ:VRNA) With A Big Upgrade This Week

Simply Wall St.

5 months ago

Analysts Are Betting On Verona Pharma plc (NASDAQ:VRNA) With A Big Upgrade This Week

Verona Pharma PLC (VRNA) Q1 2025 Earnings Call Highlights: Strong Ohtuvayre Sales Propel ...

GuruFocus.com

5 months ago

Verona Pharma PLC (VRNA) Q1 2025 Earnings Call Highlights: Strong Ohtuvayre Sales Propel ...

MT Newswires

5 months ago

Truist Securities Adjusts Verona Pharma Price Target to $100 From $76, Maintains Buy Rating

MT Newswires

5 months ago

Top Midday Gainers

MT Newswires

5 months ago

Top Premarket Gainers

MT Newswires

5 months ago

Verona Pharma Q1 Loss Narrows, Revenue Increases -- Shares Rise Pre-Bell

Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

5 months ago

Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

Verona Pharma PLC (VRNA) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

5 months ago

Verona Pharma PLC (VRNA) Q1 2025: Everything You Need To Know Ahead Of Earnings

Verona Pharma plc (VRNA): Among the Best Multibagger Stocks to Buy According to Billionaires

Insider Monkey

5 months ago

Verona Pharma plc (VRNA): Among the Best Multibagger Stocks to Buy According to Billionaires

MT Newswires

5 months ago

Cantor Fitzgerald Initiates Verona Pharma at Overweight

Ritedose to double single-vial packaging capabilities with seventh Syntegon line

Packaging Gateway

5 months ago

Ritedose to double single-vial packaging capabilities with seventh Syntegon line

Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update

GlobeNewswire

5 months ago

Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update

MT Newswires

6 months ago

Verona Pharma Re-Works Loan Packages, Boosting Borrowing Capacity, Lowering Expense

Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

GlobeNewswire

6 months ago

Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

Jim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”

Insider Monkey

6 months ago

Jim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”

Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?

Insider Monkey

6 months ago

Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?

Verona Pharma plc (VRNA): A Bull Case Theory

Insider Monkey

6 months ago

Verona Pharma plc (VRNA): A Bull Case Theory

Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus

Zacks

7 months ago

Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus

Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.

7 months ago

Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...

GuruFocus.com

7 months ago

Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...

MT Newswires

7 months ago

Truist Securities Adjusts Verona Pharma Price Target to $76 From $57, Maintains Buy Rating

MT Newswires

7 months ago

Verona Pharma Q4 Loss Widens

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

7 months ago

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Earnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 Result

GuruFocus.com

7 months ago

Earnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 Result

Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025?

Insider Monkey

7 months ago

Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025?

Verona Pharma Announces March 2025 Investor Conference Participation

GlobeNewswire

7 months ago

Verona Pharma Announces March 2025 Investor Conference Participation

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

GlobeNewswire

7 months ago

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'

Zacks

7 months ago

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA)

Zacks

8 months ago

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA)

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Insider Monkey

8 months ago

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Investor's Business Daily

8 months ago

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?

Zacks

8 months ago

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

8 months ago

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

8 months ago

Roth Initiates Verona Pharma at Buy

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long

Simply Wall St.

8 months ago

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

8 months ago

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable

MT Newswires

8 months ago

Verona Pharma to Report $36 Million in Q4 Net Product Revenue

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

GlobeNewswire

8 months ago

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

MT Newswires

10 months ago

Verona Pharma Insider Sold Shares Worth $1,176,360, According to a Recent SEC Filing

Verona Pharma Announces December 2024 Investor Conference Participation

GlobeNewswire

10 months ago

Verona Pharma Announces December 2024 Investor Conference Participation

MT Newswires

10 months ago

Verona Pharma Insider Sold Shares Worth $568,387, According to a Recent SEC Filing

MT Newswires

10 months ago

Verona Pharma Insider Sold Shares Worth $618,658, According to a Recent SEC Filing

Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years

Simply Wall St.

10 months ago

Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs

GuruFocus.com

10 months ago

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs

Verona Pharma to Present at Jefferies London Healthcare Conference

GlobeNewswire

10 months ago

Verona Pharma to Present at Jefferies London Healthcare Conference

MT Newswires

10 months ago

Verona Pharma's Q3 Loss Widens

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

10 months ago

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma PLC (VRNA) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

a year ago

Verona Pharma PLC (VRNA) Q3 2024 Earnings Report Preview: What To Expect

Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why

Zacks

a year ago

Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

Zacks

a year ago

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

Zacks

a year ago

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

MT Newswires

a year ago

Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing

MT Newswires

a year ago

Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

a year ago

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet

Zacks

a year ago

Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

a year ago

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why

MT Newswires

a year ago

Wells Fargo Initiates Verona Pharma at Overweight With $50 Price Target

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

GlobeNewswire

a year ago

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)

GuruFocus.com

a year ago

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

GuruFocus.com

a year ago

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

GlobeNewswire

a year ago

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)

GuruFocus.com

a year ago

Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)

Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?

Insider Monkey

a year ago

Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?

MT Newswires

a year ago

Verona Pharma Q2 Net Loss Widens

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability

Simply Wall St.

a year ago

Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

GlobeNewswire

a year ago

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

a year ago

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

MT Newswires

a year ago

Canaccord Genuity Raises Verona Pharma's Price Target to $37 From $35, Maintains Buy Rating

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why

Zacks

a year ago

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why

MT Newswires

a year ago

Truist Securities Raises Price Target on Verona Pharma to $38 From $32, Maintains Buy Rating

Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy

Pharmaceutical Technology

a year ago

Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

Benzinga

a year ago

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

Pharmaceutical Technology

a year ago

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

MT Newswires

a year ago

HC Wainwright Adjusts Price Target on Verona Pharma to $36 From $32, Maintains Buy Rating

MT Newswires

a year ago

Update: Verona Pharma Gets FDA Nod for Pulmonary Disease Treatment; Shares Jump Premarket

MT Newswires

a year ago

Verona Pharma Gets US FDA Approval for Ohtuvayre in Chronic Obstructive Pulmonary Disease

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

GlobeNewswire

a year ago

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

Investor's Business Daily

a year ago

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Share on Social Networks: